Thandeka Moyo-Gwete
8PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 28, 2024
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies.Kegomoditswe Malebo, Jeremy Woodward, Phindile Ximba
|Apr 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.Catherine Riou, Jinal N Bhiman, Yashica Ganga
|Dec 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.Catherine Riou, Jinal N Bhiman, Yashica Ganga
|Aug 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.Robert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson
|Dec 21, 2021
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete
|Oct 26, 2021
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African Experience.Tanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni
Pageof 2
Frequent Collaborators
4 joint publications
Wendy A Burgers
4 joint publications
Penny L Moore
4 joint publications
Catherine Riou
3 joint publications
Linda-Gail Bekker
3 joint publications
Alex Sigal
3 joint publications
Nigel Garrett
3 joint publications
Zanele Makhado
3 joint publications
Ntombi Benede
3 joint publications
Hygon Mutavhatsindi
2 joint publications
Ntobeko A B Ntusi
